BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17465260)

  • 1. Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.
    Campodonico F; Mattioli F; Manfredi V; Capponi G; Pasquini P; Martelli A; Maffezzini M
    Anticancer Res; 2007; 27(2):1179-83. PubMed ID: 17465260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic absorption and pharmacokinetics of single-dose intravesical gemcitabine after transurethral resection of the bladder in non-muscle-invasive bladder cancer.
    Maffezzini M; Campodonico F; Puntoni M; Martelli A; Mattioli F
    Urology; 2009 Nov; 74(5):1078-83. PubMed ID: 19773039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.
    Campodonico F; Canepa G; Capponi G; Bozzo L; Maffezzini M
    Anticancer Res; 2005; 25(3c):2381-4. PubMed ID: 16080464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer.
    Palou J; Carcas A; Segarra J; Duque B; Salvador J; Garcia-Ribas I; Villavicencio H
    J Urol; 2004 Aug; 172(2):485-8. PubMed ID: 15247710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study.
    Mattioli F; Curotto A; Manfredi V; Gosmar M; Garbero C; Ambruosi C; Carmignani G; Martelli A
    Anticancer Res; 2005; 25(3c):2493-6. PubMed ID: 16080482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
    Messing EM; Tangen CM; Lerner SP; Sahasrabudhe DM; Koppie TM; Wood DP; Mack PC; Svatek RS; Evans CP; Hafez KS; Culkin DJ; Brand TC; Karsh LI; Holzbeierlein JM; Wilson SS; Wu G; Plets M; Vogelzang NJ; Thompson IM
    JAMA; 2018 May; 319(18):1880-1888. PubMed ID: 29801011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study.
    Laufer M; Ramalingam S; Schoenberg MP; Haisfield-Wolf ME; Zuhowski EG; Trueheart IN; Eisenberger MA; Nativ O; Egorin MJ
    J Clin Oncol; 2003 Feb; 21(4):697-703. PubMed ID: 12586808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical gemcitabine: a phase 1 and pharmacokinetic study.
    Witjes JA; van der Heijden AG; Vriesema JL; Peters GJ; Laan A; Schalken JA
    Eur Urol; 2004 Feb; 45(2):182-6. PubMed ID: 14734004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.
    De Berardinis E; Antonini G; Peters GJ; Loves WJ; Van der Born K; Codacci-Pisanelli G; Di Silverio F
    BJU Int; 2004 Mar; 93(4):491-4. PubMed ID: 15008715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical gemcitabine for non-muscle invasive bladder cancer.
    Jones G; Cleves A; Wilt TJ; Mason M; Kynaston HG; Shelley M
    Cochrane Database Syst Rev; 2012 Jan; 1():CD009294. PubMed ID: 22259002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer].
    Cao M; Ma CK; Ma J; Chen HG; Xue W
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):385-7. PubMed ID: 21875472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.
    Böhle A; Leyh H; Frei C; Kühn M; Tschada R; Pottek T; Wagner W; Knispel HH; von Pokrzywnitzki W; Zorlu F; Helsberg K; Lübben B; Soldatenkova V; Stoffregen C; Büttner H;
    Eur Urol; 2009 Sep; 56(3):495-503. PubMed ID: 19560257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.
    Gontero P; Marini L; Frea B
    BJU Int; 2005 Nov; 96(7):970-6. PubMed ID: 16225511
    [No Abstract]   [Full Text] [Related]  

  • 14. Microemulsions for intravesical delivery of gemcitabine.
    Tsai YH; Hsieh YH; Huang YB; Chang JS; Huang CT; Wu PC
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1461-5. PubMed ID: 21048337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.
    Serretta V; Galuffo A; Pavone C; Allegro R; Pavone-MacAluso M
    Urology; 2005 Jan; 65(1):65-9. PubMed ID: 15667865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment.
    Berglund RK
    Urology; 2009 Nov; 74(5):1083; author reply 1084. PubMed ID: 19883829
    [No Abstract]   [Full Text] [Related]  

  • 17. Gemcitabine in bladder cancer.
    El Karak F; Flechon A
    Expert Opin Pharmacother; 2007 Dec; 8(18):3251-6. PubMed ID: 18035967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guérin therapy.
    Bassi P; De Marco V; Tavolini IM; Longo F; Pinto F; Zucchetti M; Crucitta E; Marini L; Dal Moro F
    Urol Int; 2005; 75(4):309-13. PubMed ID: 16327296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
    Hurmuz P; Ozyigit G; Kilickap S; Esen CSB; Akdogan B; Ozen H; Akyol F
    Urol Oncol; 2021 Jun; 39(6):368.e19-368.e29. PubMed ID: 33189528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
    Dalbagni G; Russo P; Sheinfeld J; Mazumdar M; Tong W; Rabbani F; Donat MS; Herr HW; Sogani P; dePalma D; Bajorin D
    J Clin Oncol; 2002 Aug; 20(15):3193-8. PubMed ID: 12149290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.